India's Pharmaceutical Exports

Country Profile

Tanzania

Tanzania is a major destination for Indian pharmaceutical exports — $318M in FY 2025–26, with 1.9× growth over the past decade. Medicines accounts for 84% of shipments, with vaccines contributing $20.6M. The compound annual growth rate since FY2015 stands at 6.1%.

🇹🇿 #20 Destination · $318M · 1.9× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$318M
Exports FY2025–26 DGCIS
1.9×
Growth FY2015→2026
1.0%
Share of India Total
#20
Rank Among 178 Markets
6.1%
CAGR FY2015→2026
Tanzania is a major destination for Indian pharmaceutical exports — $318M in FY 2025–26, with 1.9× growth over the past decade. Medicines accounts for 84% of shipments, with vaccines contributing $20.6M. The compound annual growth rate since FY2015 stands at 6.1%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $268M (84.1%) Medicine Ingredients $23.0M (7.2%) Vaccines $20.6M (6.5%) Surgical & Hospital Supplies $4.40M (1.4%) Traditional & Herbal $2.50M (0.8%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Tanzania in the RBI overseas direct investment dataset (2011–2026).